Depot medroxyprogesterone acetate use after peak bone mass is associated with increased bone turnover but no decrease in bone mineral density

Fertility and Sterility

Volumn 93, Issue 3, 2010, Pages 697-701

  Walsh, Jennifer S ^a   Eastell, Richard ^a   Peel, Nicola F ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

bone density; bone turnover; DMPA

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; BONE DENSITY; BONE MASS; BONE TURNOVER; CONTROLLED STUDY; FEMALE; FEMUR NECK; HIP; HUMAN; LUMBAR SPINE; OSTEOLYSIS; PRIORITY JOURNAL;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; FEMUR NECK; HUMANS; LONGITUDINAL STUDIES; LUMBAR VERTEBRAE; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 75649153286     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.10.004     Document Type: Article

References (32)

1. Kaunitz A.M., and Rosenfield A. Injectable contraception with depot medroxyprogesterone acetate. Drug 45 (1993) 854-865
2. Mainwaring R., Hales H.A., Stevenson K., Poulson A.M., Jones K.P., and Peterson C.M. Metabolic parameters, bleeding and weight change in women using progestin only contraceptives. Contraception 51 (1995) 149-153
3. Cundy T., Evans M., Roberts H., Wattie D., Ames R., and Reid I.R.R. Bone density in women receiving depot medroxyprogesterone acetate for contraception. Br Med J 303 (1991) 13-16
4. Cundy T., Cornish J., Roberts H., Elder H., and Reid I.R. Spinal bone density in women using depot medroxyprogesterone acetate contraception. Obstet Gynecol 92 (1998) 569-573
5. Paiva L.C., Pinto-Neto A.M., and Faundes A. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive. Contraception 58 (1998) 351-355
6. Scholes D., Lacroix A.Z., Ott S.M., Ichikawa L.E., and Barlow W.E. Bone mineral density in women using depot medroxyprogesterone acetate for contraception. Obstet Gynecol 93 (1999) 233-238
7. Tang O.S., Tang G., Yip P., Li B., and Fan S. Long-term depot medroxyprogesterone acetate and bone mineral density. Contraception 59 (1999) 25-29
8. Clark M.K., Sowers M., Nichols S., and Levy B. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Fertil Steril 82 (2004) 1580-1586
9. Wanichsetakul P., Kamudhamas A., Watanaruangkovit P., Siripakarn Y., and Visutakul P. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot medroxyprogesterone acetate for contraception. Contraception 65 (2002) 407-410
10. Petitti D.B., Piaggio G., Mehta S., Cravioto M.C., and Meirik O. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health. Obstet Gynecol 95 (2000) 736-744
11. Naessen T., Olsson S.-E., and Gudmundson J. Differential effects on bone density of progestogen-only methods of contraception. Contraception 52 (1995) 35-39
12. Taneepanichskul S., Intaraprasert S., Theppisai U., and Chaturachinda K. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors. Contraception 56 (1997) 1-3
13. Perrotti M., Bahamondes L., Petta C., and Castro S. Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate. Fertil Steril 76 (2001) 469-473
14. Merki-Field G.S., Neff M., and Keller P.J. A prospective study on the effects of depot medroxyprogesterone acetate on trabecular and cortical bone after attainment of peak bone mass. Br J Obstet Gynaecol 107 (2000) 863-869
15. Cromer B.A., Blair J.M., Mahan J.D., Zibners L., and Naumovski Z. A prospective comparison of bone density in girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant) or oral contraceptives. J Pediatr 129 (1996) 671-676
16. Busen N.H., Britt R.B., and Rianon N. Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years. J Adolesc Health 32 (2003) 257-259
17. Cromer B.A., Stager M., Bonny A., Lazebnik R., Rome E., Ziegler J., et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health 35 (2004) 434-441
18. Scholes D., Lacroix A.Z., Ichikawa L.E., Barlow W.E., and Ott S.M. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women. Contraception 69 (2004) 99-104
19. Lara-Torre E., Edwards C.P., Perlman S., and Hertweck S.P. Bone mineral density in adolescent females using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol 17 (2004) 17-21
20. Shaarawy M., El-Mallah S.Y., Seoudi S., Hassan M., and Mohsen I.A. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodelling. Contraception 74 (2006) 297-302
21. Ott S.M., Scholes D., LaCroix A.Z., Ichikawa L.E., Yoshida C.K., and Barlow W.E. Effects of contraceptive use on bone biochemical markers in young women. J Clin Endocrinol Metab 86 (2001) 179-185
22. Walsh J.S., Eastell R., and Peel N.F. Effects of depot medroxyprogesterone acetate on bone density and bone metabolism before and after peak bone mass: a case-control study. J Clin Endocrinol Metab 93 (2008) 1317-1323
23. Cundy T., Cornish J., Evans M.C., Roberts H., and Reid I.R. Recovery of bone density in women who stop using medroxyprogesterone acetate. Br Med J 308 (1994) 247-248
24. Scholes D., LaCroix A.Z., Ichikawa L.E., Barlow W.E., and Ott S.M. Injectable hormonal contraception and bone density: results from a prospective study. Epidemiol 13 (2002) 581-587
25. Kaunitz A.M., Miller P.D., Montgomery Rice V., Ross D., and McClung M.R. Bone mineral density in women aged 25-35 receiving depot medroxyprogesterone acetate: recovery following discontinuation. Contraception 74 (2006) 90-99
26. Clark M.K., Sowers M., Levy B., and Nichols S. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate. Fertil Steril 86 (2006) 1466-1474
27. Hertweck S.P., Harel Z., Stager M., Gold M.A., Coupey S.M., and Burkman R.T. Evaluation of bone mineral density in adolescents during use of depot medroxyprogesterone acetate intramuscular injection and after discontinuation. Obstet Gynecol 107 (2006) 51S
28. Scholes D., LaCroix A.Z., Ichikawa L.E., Barlow W.E., and Ott S.M. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med 159 (2005) 139-144
29. Tang O.S., Tang G., Yip P.S.F., and Li B. Further evaluation on long-term depot medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort study. Contraception 62 (2000) 161-164
30. Cundy T., Cornish K.J., Roberts H., and Reid I.R. Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception. Am J Obstet Gynecol 186 (2002) 978-983
31. Peris P., Alvarez L., Monegal A., Guanabens N., Duran M., Pons F., et al. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy. Bone 25 (1999) 349-353
32. Seifert-Klaus V., Mueller J., Luppa P., Probst R., Wilker J., Hoβ C., et al. Bone metabolism during the perimenopausal transition: a prospective study. Maturitas 41 (2002) 23-33